Literature DB >> 8241016

Hypertensive labeling (reply to Dr. Birkenhäger's editorial)

P Lund-Johansen.   

Abstract

Entities:  

Mesh：

Year:  1993        PMID： 8241016     DOI： 10.1007/bf00877827

Source DB:  PubMed          Journal:  Cardiovasc Drugs Ther        ISSN： 0920-3206            Impact factor:   3.727


× No keyword cloud information.
  5 in total

1.  Bishop lecture. Contribution of the Framingham Study to preventive cardiology.

Authors:  W B Kannel
Journal:  J Am Coll Cardiol       Date:  1990-01       Impact factor: 24.094

2.  Awareness of hypertension increases blood pressure and sympathetic responses to cold pressor test.

Authors:  M Rostrup; S E Kjeldsen; I K Eide
Journal:  Am J Hypertens       Date:  1990-12       Impact factor: 2.689

Review 3.  Hemodynamic and neurohumoral evidence of multifaceted pathophysiology in human hypertension.

Authors:  S Julius
Journal:  J Cardiovasc Pharmacol       Date:  1990       Impact factor: 3.105

4.  Untreated mild hypertension. A report by the Management Committee of the Australian Therapeutic Trial in Mild Hypertension.

Authors: 
Journal:  Lancet       Date:  1982-01-23       Impact factor: 79.321

5.  Hypertensive labeling: does it have therapeutic implications.

Authors:  W H Birkenhäger
Journal:  Cardiovasc Drugs Ther       Date:  1993-04       Impact factor: 3.727
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.